Derrell Porter, MD, MBA

Over 20 years experience in biopharma space, bringing deep interdisciplinary expertise in the development and commercialization of innovative therapeutics in oncology and cell and gene therapy

Served as founder and CEO of Cellevolve Bio, working with partners ato bring cell therapies through late-stage development and commercialization with a focus on neglected diseases

Held various leadership roles at Atara Bio, Gilead Sciences, AbbVie, Amgen and McKinsey & Company

Currently sits on the boards of Passage Bio, Acumen Pharma and Portal Innovations

Earned his M.D. from the University of Pennsylvania's Perelman School of Medicine, M.B.A. from the Wharton School, and B.S. in Neuroscience from UCLA.